These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 26390291)

  • 1. Altered Osteocyte-Specific Protein Expression in Bone after Childhood Solid Organ Transplantation.
    Pereira RC; Valta H; Tumber N; Salusky IB; Jalanko H; Mäkitie O; Wesseling Perry K
    PLoS One; 2015; 10(9):e0138156. PubMed ID: 26390291
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Osteocyte Protein Expression Is Altered in Low-Turnover Osteoporosis Caused by Mutations in WNT1 and PLS3.
    Wesseling-Perry K; Mäkitie RE; Välimäki VV; Laine T; Laine CM; Välimäki MJ; Pereira RC; Mäkitie O
    J Clin Endocrinol Metab; 2017 Jul; 102(7):2340-2348. PubMed ID: 28379384
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vitamin D sterols increase FGF23 expression by stimulating osteoblast and osteocyte maturation in CKD bone.
    Pereira RC; Salusky IB; Bowen RE; Freymiller EG; Wesseling-Perry K
    Bone; 2019 Oct; 127():626-634. PubMed ID: 31377240
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Osteocytic protein expression response to doxercalciferol therapy in pediatric dialysis patients.
    Pereira RC; Jüppner H; Gales B; Salusky IB; Wesseling-Perry K
    PLoS One; 2015; 10(3):e0120856. PubMed ID: 25774916
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serum level of fibroblast growth factor 23 in maintenance renal transplant patients.
    Sánchez Fructuoso AI; Maestro ML; Pérez-Flores I; Valero R; Rafael S; Veganzones S; Calvo N; De la Orden V; De la Flor JC; Valga F; Vidaurreta M; Fernández-Pérez C; Barrientos A
    Nephrol Dial Transplant; 2012 Nov; 27(11):4227-35. PubMed ID: 23144073
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The complexity of chronic kidney disease-mineral and bone disorder across stages of chronic kidney disease.
    Graciolli FG; Neves KR; Barreto F; Barreto DV; Dos Reis LM; Canziani ME; Sabbagh Y; Carvalho AB; Jorgetti V; Elias RM; Schiavi S; Moysés RMA
    Kidney Int; 2017 Jun; 91(6):1436-1446. PubMed ID: 28318623
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High calcium, phosphate and calcitriol supplementation leads to an osteocyte-like phenotype in calcified vessels and bone mineralisation defect in uremic rats.
    Bisson SK; Ung RV; Picard S; Valade D; Agharazii M; Larivière R; Mac-Way F
    J Bone Miner Metab; 2019 Mar; 37(2):212-223. PubMed ID: 29603070
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Osteocyte deficiency in hip fractures.
    Delgado-Calle J; Arozamena J; García-Renedo R; García-Ibarbia C; Pascual-Carra MA; González-Macías J; Riancho JA
    Calcif Tissue Int; 2011 Oct; 89(4):327-34. PubMed ID: 21874545
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association of Serum Sclerostin with Bone Sclerostin in Chronic Kidney Disease is Lost in Glucocorticoid Treated Patients.
    Boltenstål H; Qureshi AR; Behets GJ; Lindholm B; Stenvinkel P; D'Haese PC; Haarhaus M
    Calcif Tissue Int; 2019 Feb; 104(2):214-223. PubMed ID: 30406279
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bone mineralization is regulated by signaling cross talk between molecular factors of local and systemic origin: the role of fibroblast growth factor 23.
    Sapir-Koren R; Livshits G
    Biofactors; 2014; 40(6):555-68. PubMed ID: 25352227
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of dietary phosphate on adynamic bone disease in rats with chronic kidney disease--role of sclerostin?
    Ferreira JC; Ferrari GO; Neves KR; Cavallari RT; Dominguez WV; Dos Reis LM; Graciolli FG; Oliveira EC; Liu S; Sabbagh Y; Jorgetti V; Schiavi S; Moysés RM
    PLoS One; 2013; 8(11):e79721. PubMed ID: 24236156
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impaired osteocyte maturation in the pathogenesis of renal osteodystrophy.
    Pereira RC; Salusky IB; Roschger P; Klaushofer K; Yadin O; Freymiller EG; Bowen R; Delany AM; Fratzl-Zelman N; Wesseling-Perry K
    Kidney Int; 2018 Nov; 94(5):1002-1012. PubMed ID: 30348285
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sclerostin, Osteocytes, and Chronic Kidney Disease - Mineral Bone Disorder.
    Moysés RM; Schiavi SC
    Semin Dial; 2015; 28(6):578-86. PubMed ID: 26288182
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fibroblast growth factor-23 and chronic allograft injury in pediatric renal transplant recipients: a Midwest Pediatric Nephrology Consortium study.
    Seifert ME; Ashoor IF; Chiang ML; Chishti AS; Dietzen DJ; Gipson DS; Janjua HS; Selewski DT; Hruska KA
    Pediatr Transplant; 2016 May; 20(3):378-87. PubMed ID: 26880121
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The influence of glomerular filtration rate and age on fibroblast growth factor 23 serum levels in pediatric chronic kidney disease.
    Bacchetta J; Dubourg L; Harambat J; Ranchin B; Abou-Jaoude P; Arnaud S; Carlier MC; Richard M; Cochat P
    J Clin Endocrinol Metab; 2010 Apr; 95(4):1741-8. PubMed ID: 20157196
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Altered skeletal expression of sclerostin and its link to radiographic progression in ankylosing spondylitis.
    Appel H; Ruiz-Heiland G; Listing J; Zwerina J; Herrmann M; Mueller R; Haibel H; Baraliakos X; Hempfing A; Rudwaleit M; Sieper J; Schett G
    Arthritis Rheum; 2009 Nov; 60(11):3257-62. PubMed ID: 19877044
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Patterns of FGF-23, DMP1, and MEPE expression in patients with chronic kidney disease.
    Pereira RC; Juppner H; Azucena-Serrano CE; Yadin O; Salusky IB; Wesseling-Perry K
    Bone; 2009 Dec; 45(6):1161-8. PubMed ID: 19679205
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dialysis vintage and parathyroid hormone level, not fibroblast growth factor-23, determines chronic-phase phosphate wasting after renal transplantation.
    Tomida K; Hamano T; Ichimaru N; Fujii N; Matsui I; Nonomura N; Tsubakihara Y; Rakugi H; Takahara S; Isaka Y
    Bone; 2012 Oct; 51(4):729-36. PubMed ID: 22796419
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sclerostin blood levels before and after kidney transplantation.
    Bonani M; Rodriguez D; Fehr T; Mohebbi N; Brockmann J; Blum M; Graf N; Frey D; Wüthrich RP
    Kidney Blood Press Res; 2014; 39(4):230-9. PubMed ID: 25118597
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sclerostin, Osteocytes, and Wnt Signaling in Pediatric Renal Osteodystrophy.
    Laster M; Pereira RC; Noche K; Gales B; Salusky IB; Albrecht LV
    Nutrients; 2023 Sep; 15(19):. PubMed ID: 37836411
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.